BioSpace News Archive

BioForest

Alpine Immune Sciences Set to Join Russell 3000® Index

Alpine Immune Sciences, Inc. announced Alpine is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, 2021, according to a preliminary list of additions posted by FTSE Russell on June 4, 2021.

June 8, 2021
·
5 min read
Policy

MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan

MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced successful regulatory approval by the Japanese Ministry of Health, Labour and Welfare (JMHLW) to market EPIFIX® in Japan.

June 8, 2021
·
5 min read
EyeYon Medical Receives CE Mark for its EndoArt® Implant to Treat Chronic Corneal Edema

EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announced today that it has received CE Mark for its EndoArt®, after clinical trials demonstrated safety and efficacy for treating chronic corneal edema.

June 8, 2021
·
3 min read
Drug Development

Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO)

Evaluating the safety, tolerability, and efficacy of intravenous (IV) temanogrel for cMVO in adult participants undergoing percutaneous coronary intervention (PCI).

June 8, 2021
·
6 min read
Biotech Beach

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

Allergan Aesthetics, an AbbVie company, is changing the way BOTOX® Cosmetic, the #1 selling neurotoxin treatment1, is connecting with consumers.

June 8, 2021
·
9 min read
Deals

Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

Lux Capital, Mubadala Capital, Obvious Ventures, and DCVC among founding group supporting underrepresented founders building next-generation healthcare companies

June 8, 2021
·
5 min read
Sparta(TM) Unveils Multi-Layer Virus Protection Program for the Workplace

Sparta Group is officially unveiling its virus protection program for the workplace. It’s a system that integrates 5 easy-to-use components that can be utilized by both industrial and commercial enterprises to help keep a lid on the spread of viruses like COVID-19.

June 8, 2021
·
6 min read
Pharm Country

Bioclinica Adds eConsent Functionality to Its Electronic Data Capture and Management Suite of Products

Bioclinica, an ERT company, announced the addition of eConsent as part of its Electronic Data Capture and Management suite of products.

June 8, 2021
·
2 min read
Drug Development

Citius Pharmaceuticals Achieves Next Interim Analysis Milestone in its Mino-Lok® Phase 3 Trial

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), today announced that the next planned interim analysis in its Phase 3 trial of Mino-Lok.

June 8, 2021
·
6 min read
Pharm Country

Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) To Be Covered Under Medicare Part B Effective July 18, Improving Access and Reducing Out-of-Pocket Costs for CIDP Patients

Global biotherapeutics leader CSL Behring today announced that the Centers for Medicare & Medicaid Services (CMS) has approved Hizentra for coverage under Medicare Part B for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

June 8, 2021
·
8 min read